237 related articles for article (PubMed ID: 21400753)
1. [Cycloferon efficacy of therapy of chronic hepatitis B (results of randomized multicentre study)].
Sologub TV; Shul'diakov AA; Goriacheva LG; Baranova IP; Lin'kova IuN; Kovalenko AL; Romantsov MG
Antibiot Khimioter; 2010; 55(9-10):37-41. PubMed ID: 21400753
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy of chronic viral hepatitis B: randomized multicenter investigation results].
Romantsov MG; Sologub TV; Shul'diakov AA; Goriacheva LG; Lin'kova IuN; Kovalenko AL
Eksp Klin Farmakol; 2010 Nov; 73(11):30-3. PubMed ID: 21254596
[TBL] [Abstract][Full Text] [Related]
3. [Comparative efficacy of etiotropic therapy of patients with HBeAg-positive chronic hepatitis B (by the data of the international comparative placebo-controlled study)].
Stel'makh VV; Romantsov MG; Sologub TV; Shul'diakov AA; Kozlov VK; Tuan NKh; Oyungerel M; Frolov VM
Antibiot Khimioter; 2013; 58(9-10):27-33. PubMed ID: 24738240
[TBL] [Abstract][Full Text] [Related]
4. [Cycloferon therapy of acute and chronic virus hepatitis C].
Malyĭ VP; Pen'kov DV; Chiriukina OI
Antibiot Khimioter; 2013; 58(9-10):34-40. PubMed ID: 24738241
[TBL] [Abstract][Full Text] [Related]
5. [Rational pharmacotherapy and correction of immunity disorders in children with chronic hepatitis (clinical review)].
Goriacheva LG; Romantsov MG; Agaeva SG; Lin'kov IuN; Kovalenko AL
Antibiot Khimioter; 2010; 55(5-6):50-7. PubMed ID: 21033475
[TBL] [Abstract][Full Text] [Related]
6. Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy.
Suzuki F; Tsubota A; Akuta N; Someya T; Kobayashi M; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Miyakawa Y; Kumada H
J Gastroenterol; 2002; 37(11):922-7. PubMed ID: 12483247
[TBL] [Abstract][Full Text] [Related]
7. Phase IIb trial of
Yang FQ; Rao GR; Wang GQ; Li YQ; Xie Y; Zhang ZQ; Deng CL; Mao Q; Li J; Zhao W; Wang MR; Han T; Chen SJ; Pan C; Tan DM; Shang J; Zhang MX; Zhang YX; Yang JM; Chen GM
World J Gastroenterol; 2017 Jan; 23(2):306-317. PubMed ID: 28127204
[TBL] [Abstract][Full Text] [Related]
8. [Clinical efficacy of cycloferon in complex therapy of infectious mononucleosis in pediatrics].
Kasymova EB; Bashkina OA; Galimzianov KhM
Antibiot Khimioter; 2011; 56(9-10):37-40. PubMed ID: 22586903
[TBL] [Abstract][Full Text] [Related]
9. [Cycloferon, as an agent in the therapy and urgent prophylaxis of influenza and acute respiratory tract viral infection (multicentre randomized controlled comparative study)].
Sologub TV; Shul'diakov AA; Romantsov MG; Zhekalov AN; Petlenko SV; Erofeeva MK; Maksakova VL; Isakov VA; Zarubaev VV; Gatsan VV; Kovalenko AL
Antibiot Khimioter; 2009; 54(7-8):30-2, 34-6. PubMed ID: 20201401
[TBL] [Abstract][Full Text] [Related]
10. Interferon/long-term lamivudine combination therapy in anti-HBe positive chronic hepatitis B patients.
Nikolaidis NL; Giouleme OI; Tziomalos KA; Saveriadis AS; Grammatikos N; Doukelis P; Voutsas AD; Vassiliadis T; Patsiaoura K; Orfanou-Koumerkeridou E; Balaska A; Eugenidis NP
J Gastroenterol Hepatol; 2005 Nov; 20(11):1721-5. PubMed ID: 16246192
[TBL] [Abstract][Full Text] [Related]
11. In vivo immunization by vaccine therapy following virus suppression by lamivudine: a novel approach for treating patients with chronic hepatitis B.
Horiike N; Fazle Akbar SM; Michitaka K; Joukou K; Yamamoto K; Kojima N; Hiasa Y; Abe M; Onji M
J Clin Virol; 2005 Feb; 32(2):156-61. PubMed ID: 15653419
[TBL] [Abstract][Full Text] [Related]
12. Clinical course and predictive factors of virological response in long-term lamivudine plus adefovir dipivoxil combination therapy for lamivudine-resistant chronic hepatitis B patients.
Aizawa M; Tsubota A; Fujise K; Tatsuzawa K; Kono M; Hoshina S; Tajiri H
J Med Virol; 2011 Jun; 83(6):953-61. PubMed ID: 21503906
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic efficacy of various formulations of cycloferon in the treatment of infectious mononucleosis in children].
Kurmaeva DIu; Baranova IP
Antibiot Khimioter; 2011; 56(9-10):33-6. PubMed ID: 22586902
[TBL] [Abstract][Full Text] [Related]
14. [Efficiency of using cycloferon as part of combined therapy for chronic hepatitis C (a review of multicenter clinical trials)].
Sologub TV; Romantsev MG; Shul'diakov AA; Lin'kova IuN; Radchenko VG; Kovalenko AL
Ter Arkh; 2010; 82(10):78-81. PubMed ID: 21341470
[TBL] [Abstract][Full Text] [Related]
15. One two tandem of lamivudine and inferferon might work for patients with chronic hepatitis B who failed inferferon monotherapy.
Kaplan DD; Reddy KR
Am J Gastroenterol; 2002 Sep; 97(9):2465-7. PubMed ID: 12358276
[No Abstract] [Full Text] [Related]
16. Does the addition of lamivudine to peginterferon alpha-2a sustain response rates in HBeAg-negative hepatitis B?
Cooksley G
Nat Clin Pract Gastroenterol Hepatol; 2005 Jan; 2(1):12-3. PubMed ID: 16265091
[No Abstract] [Full Text] [Related]
17. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
18. Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine.
Manolakopoulos S; Bethanis S; Koutsounas S; Goulis J; Vlachogiannakos J; Christias E; Saveriadis A; Pavlidis C; Triantos C; Christidou A; Papatheodoridis G; Karamanolis D; Tzourmakliotis D
Aliment Pharmacol Ther; 2008 Feb; 27(3):266-73. PubMed ID: 17988233
[TBL] [Abstract][Full Text] [Related]
19. Remission of breakthrough hepatitis in chronic hepatitis B patients on lamivudine.
Koike K
J Gastroenterol; 2002; 37(11):988-90. PubMed ID: 12483259
[No Abstract] [Full Text] [Related]
20. Chronic hepatitis B: back to the future with HBsAg.
Moucari R; Lada O; Marcellin P
Expert Rev Anti Infect Ther; 2009 Aug; 7(6):633-6. PubMed ID: 19681689
[No Abstract] [Full Text] [Related]
[Next] [New Search]
